Interventions for dysphagia in long-term, progressive muscle disease

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 2, 2016, Pages

  Jones, Katherine ^a   Pitceathly, Robert D S ^b,c   Rose, Michael R ^a   Mcgowan, Susan ^c   Hill, Marguerite ^d   Badrising, Umesh A ^e   Hughes, Tom ^f  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d MORRISTON HOSPITAL   (United Kingdom)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PLACEBO; IMMUNOGLOBULIN; IMMUNOLOGIC FACTOR;

CINAHL; COCHRANE LIBRARY; DRUG EFFICACY; DYSPHAGIA; EMBASE; EXERCISE; FOLLOW UP; HEADACHE; HUMAN; INCLUSION BODY MYOSITIS; INTERVENTION STUDY; MEDLINE; META ANALYSIS; MUSCLE DISEASE; MYOTONIC DYSTROPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SWALLOWING; SYSTEMATIC REVIEW; WEIGHT GAIN; WORLD HEALTH ORGANIZATION; ADULT; CHILD; CHRONIC DISEASE; COMPLICATION; DEGLUTITION DISORDERS; MUSCULAR DISEASES; MYOSITIS, INCLUSION BODY;

ADULT; CHILD; CHRONIC DISEASE; DEGLUTITION; DEGLUTITION DISORDERS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MUSCULAR DISEASES; MYOSITIS, INCLUSION BODY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84969528786     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004303.pub4     Document Type: Review

References (45)

1. Dalakas MC, Sonies B, Dambrosia J, Sekul E, Cupler E, Sivakumar K. Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study. Neurology 1997;48(3):712-6. [PUBMED: 9065553]
2. Dobloug C, Walle-Hansen R, Gran JT, Molberg Ø. Long-term follow-up of sporadic inclusion body myositis treated with intravenous immunoglobulin: a retrospective study of 16 patients. Clinical and Experimental Rheumatology 2012;30(6):838-42. [PUBMED: 22935197]
3. Horowitz M, Maddox A, Maddern GJ, Wishart J, Collins PJ, Shearman DJ. Gastric and esophageal emptying in dystrophia myotonica. Effect of metoclopramide. Gastroenterology 1987;92(3):570-7. [PUBMED: 3817383]
4. NCT00773227 . Treatment of dysphagia in oculopharyngeal muscular dystrophy by autologous transplantation of myoblasts. http://clinicaltrials.gov/show/NCT00773227 (accessed 12 January 2016).
5. Sjögreen L, Tulinius M, Kiliaridis S, Lohmander A. The effect of lip strengthening exercises in children and adolescents with myotonic dystrophy type 1. International Journal of Pediatric Otorhinolaryngology 2010;74(10):1126-34. [PUBMED: 20638139]
6. ISRCTN84905610 . Comparative study on treatment methods in cricopharyngeal dysfunction. http://apps.who.int/trialsearch/trial2.aspx?trialid=isrctn84905610 (accessed 12 January 2016).
7. NCT02328482 . Continuation protocol to protocol BBCO-001. http://clinicaltrials.gov/show/NCT02328482 (accessed 12 January 2016).
8. Abu-Baker A, Rouleau GA. Oculopharyngeal muscular dystrophy: Recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies. Biochimica et Biophysica Acta 2007;1772:173-85.
9. Archer SK, Garrod R, Hart N, Miller S. Dysphagia in Duchenne muscular dystrophy assessed by validated questionnaire. International Journal of Language & Communication Disorders 2013;48(2):240-6.
10. Arvedson J, Clark H, Lazarus C, Schooling T, Frymark T. The effects of oral-motor exercises on swallowing in children: an evidence-based systematic review. Developmental Medicine and Child Neurology 2010;52(11):1000-13.
11. Bülow M, Olsson R, Ekberg O. Videomanometric analysis of supraglottic swallow, effortful swallow, and chin tuck in patients with pharyngeal dysfunction. Dysphagia 2001;16(3):190-5.
12. Cox FM, Verschuuren JJ, Verbist BM, Niks EH, Wintzen AR, Badrising UA. Detecting dysphagia in inclusion body myositis. Neurology 2009;256(12):2009-13.
13. Cox FM, Titulaer MJ, Sont JK, Wintzen AR, Verschuuren JJ, Badrising UA. A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities. Brain 2011;134(Pt 11):3167-75.
14. Darrow DH, Hoffman HT, Barnes GJ, Wiley CA. Management of dysphagia in inclusion body myositis. Archives of Otolaryngology - Head and Neck Surgery 1992;118(3):313-7.
15. Drake W, O'Donoghue S, Bartram C, Lindsay J, Greenwood R. Eating in side-lying facilitates rehabilitation in neurogenic dysphagia. Brain Injury 1997;11(2):137-42.
16. Durmus H, Laval SH, Deymeer F, Parman Y, Kiyan E, Gokyigiti M, et al. Oculopharyngodistal myopathy is a distinct entity: clinical and genetic features of 47 patients. Neurology 2011;76(3):227-35.
17. Ertekin C, Keskin A, Kiylioglu N, Kirazli Y, On AY, Tarlaci S, et al. The effect of head and neck positions on oropharyngeal swallowing: a clinical and electrophysiologic study. Archives of Physical Medicine and Rehabilitation 2001;82(9):1255-60.
18. Ganger D, Craig RM. Swallowing disorders and nutritional support. Dysphagia 1990;4(4):213-9.
19. Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, et al. Inclusion body myositis and myopathies. Annals of Neurology 1995;38(5):705-13.
20. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
21. Hill M, Hughes T. Workshop: Management of adults and children with feeding difficulties secondary to chronic muscle disease, 22nd March 2002, Sheffield, UK. Neuromuscular Disorders 2002;12(10):970-4.
22. Hughes TA, Wiles CM. Clinical measurement of swallowing in health and in neurogenic dysphagia. Quarterly Journal of Medicine 1996;89(2):109-16.
23. Jaradeh S. Muscle disorders affecting oral and pharyngeal swallowing. GI Motility Online 2006. [DOI: ]
24. Logemann JA, Rademaker AW, Pauloski BR, Kahrilas PJ. Effects of postural change on aspiration in head and neck surgical patients. Otolaryngology - Head and Neck Surgery 1994;110(2):222-7.
25. Low J, Wyles C, Wilkinson T, Sainsbury R. The effect of compliance on clinical outcomes for patients with dysphagia on videofluoroscopy. Dysphagia 2001;16(2):123-7.
26. Malandraki GA, Kaufman A, Hind J, Ennis S, Gangnon R, Waclawik A, et al. The effects of lingual intervention in a patient with inclusion body myositis and Sjögren's syndrome: a longitudinal case study. Archives of Physical Medicine and Rehabilitation 2012;93(8):1469-75.
27. Martin AW. Dietary management of swallowing disorders. Dysphagia 1991;6(3):129-34.
28. McCann LJ, Garay SM, Ryan MM, Harris R, Riley P, Pilkington CA. Oropharyngeal dysphagia in juvenile dermatomyositis (JDM): an evaluation of videofluoroscopy swallow study (VFSS) changes in relation to clinical symptoms and objective muscle scores. Rheumatology 2007;46(8):1363-6.
29. McCullough GH, Kamarunas E, Mann GC, Schmidley JW, Robbins JA, Crary MA. Effects of Mendelsohn maneuver on measures of swallowing duration post stroke. Top Stroke Rehabilitation 2012;19(3):234-43.
30. Norton B, Homer-Ward M, Donnelly MT, Long RG, Holmes GK. A randomised prospective comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding after acute dysphagic stroke. BMJ 1996;312(7022):13-6.
31. O'Gara JA. Dietary adjustments and nutritional therapy during treatment for oral-pharyngeal dysphagia. Dysphagia 1990;4(4):209-12.
32. Oh TH, Brumfield KA, Hoskin TL, Kasperbauer JL, Basford JR. Dysphagia in inclusion body myositis: clinical features, management, and clinical outcome. American Journal of Physical Medicine and Rehabilitation 2008;87(11):883-9.
33. Palmer PM, Neel AT, Sprouls G, Morrison L. Swallow characteristics in patients with oculopharyngeal muscular dystrophy. Journal of Speech, Language & Hearing Research 2010;53(6):1567-78.
34. Pandolfino JE, Kahrilas PJ, American Gastroenterological Association. AGA technical review on the clinical use of esophageal manometry. Gastroenterology 2005;128(1):209-24.
35. Philpot J, Bagnall A, King C, Dubowitz V, Muntoni F. Feeding problems in merosin deficient congenital muscular dystrophy. Archives of Disease in Childhood 1999;80(6):542-7.
36. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
37. Rose MR, Jones, K, Leong K, Walter MC, Miller J, Dalakas MC, et al. Treatment for inclusion body myositis. Cochrane Database of Systematic Reviews 2015, Issue 6. [DOI: ]
38. Scott A, Perry A, Bench J. A study of interrater reliability when using videofluoroscopy as an assessment of swallowing. Dysphagia 1998;13(4):223-7.
39. Seguy D, Michaud L, Guimber D, Cuisset JM, Devos P, Turck D, et al. Efficacy and tolerance of gastrostomy feeding in pediatric forms of neuromuscular diseases. Journal of Parenteral and Enteral Nutrition 2002;26(5):298-304.
40. Straathof CS, Doorenweerd N, Wokke BH, Dumas EM, van den Bergen JC, van Buchem MA, et al. Temporalis muscle hypertrophy and reduced skull eccentricity in Duchenne muscular dystrophy. Journal of Child Neurology 2014;29(10):1344-8.
41. Tieleman AA, Knuijt S, van Vliet J, de Swart BJ, Ensink R, van Engelen BG. Dysphagia is present but mild in myotonic dystrophy type 2. Neuromuscular Disorders 2009;19:196-8.
42. Willig TN, Paulus J, Lacau Saint Guily J, Béon C, Navarro J. Swallowing problems in neuromuscular disorders. Archives of Physical Medicine & Rehabilitation 1994;75(11):1175-81.
43. Wintzen AR, Bots GT, de Bakker HM, Hulshof JH, Padberg GW. Dysphagia in inclusion body myositis. Journal of Neurology, Neurosurgery and Psychiatry 1988;51(12):1542-5.
44. Hill M, Hughes T, Milford C. Treatment for dysphagia in chronic muscle disease. Cochrane Database of Systematic Reviews 2002, Issue 4. [DOI: ]
45. Hill M, Hughes T, Milford C. Treatment for swallowing difficulties (dysphagia) in chronic muscle disease. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: ]